Leukocyte-mimicking nanovesicles for effective doxorubicin delivery to treat breast cancer and melanoma-Reference-Cited by-同舟云学术

Leukocyte-mimicking nanovesicles for effective doxorubicin delivery to treat breast cancer and melanoma

Published:2020 Issue:1 Volume:8 Page:333-341
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Molinaro Roberto¹²³⁴⁵^ORCID,Martinez Jonathan O.¹²³⁴,Zinger Assaf¹²³⁴,De Vita Alessandro¹²³⁴⁶^ORCID,Storci Gianluca¹²³⁴⁷,Arrighetti Noemi¹²³⁴⁸,De Rosa Enrica¹²³⁴,Hartman Kelly A.¹²³⁴,Basu Nupur¹²³⁴,Taghipour Nima¹²³⁴,Corbo Claudia¹²³⁴⁹^ORCID,Tasciotti Ennio¹²³⁴¹⁰

Affiliation:

1. Regenerative Medicine Program

2. Houston Methodist Research Institute

3. Houston

4. USA

5. School of Pharmacy

6. Osteoncology and Rare Tumors Center

7. Departmentof Experimental

8. Department of Applied Research and Technological Development

9. School of Medicine and Surgery

10. Houston Methodist Orthopedics and Sports Medicine

Abstract

Biomimetic nanovesicles deriving from leukocytes membrane proteins, called leukosomes, exhibit increased targeting of cancer vasculature and stroma by exploiting the inflammatory pathway responsible for recruiting immune cells to the cancer lesion.

Funder

Associazione Bianca Garavaglia

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2020/BM/C9BM01766F

Reference40 articles.

1. Clinical translation of nanomedicines

2. Endosomal escape pathways for delivery of biologicals

3. Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors